Navigation Links
Palatin Technologies Reports Positive Results for Phase 2B Bremelanotide Female Sexual Dysfunction Trial
Date:11/8/2012

CRANBURY, N.J., Nov. 8, 2012 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) today reported positive top-line results, including the successful achievement of statistical significance for the primary endpoint and key secondary endpoints in its Phase 2B clinical trial evaluating the efficacy and safety of bremelanotide for the treatment of female sexual dysfunction (FSD).

The data demonstrate that women taking bremelanotide showed statistically significant increases in the number of Satisfying Sexual Events (SSEs) and also showed statistically significant improved measures of overall sexual functioning and distress related to sexual dysfunction, compared with placebo.

The primary endpoint data analysis of 327 pre-menopausal women with female sexual arousal disorder (FSAD), hypoactive sexual desire disorder (HSDD), or a combination of both disorders, the most common types of FSD, shows a clinically meaningful and statistically significant improvement (p=0.018) in the number of SSEs in women taking bremelanotide doses (mean change from 1.6 at baseline increasing to 2.4; pooled 1.25 mg and 1.75 mg doses) versus placebo (mean change from 1.7 at baseline increasing to 1.9) over the study period, resulting in a 50% increase in SSEs with bremelanotide versus 12% with placebo.

"We are extremely pleased to report the successful completion of this trial, which achieved statistical significance in our primary endpoint and key secondary endpoints using independently developed and validated measurement tools. Importantly, we met the objectives of the trial which demonstrated excellent safety and efficacy of the drug and identified doses for advancement into Phase 3 trials and activities" stated Carl Spana, Ph.D., President and CEO of Palatin. "Our next steps are to continue to compile and analyze additional data, to start the preparation process for an end-of-Phase 2 meeting with the FDA, and to further our discussions with potential colla
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
2. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
3. Palatin Technologies to Present at Windhovers Therapeutic Area Partnerships Conference
4. Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference
5. Palatin Technologies, Inc. To Report Fiscal Year 2012 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2012
6. Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on May 14, 2012
7. Palatin Technologies Announces Halting of Phase I Clinical Trial of Obesity Compound in AstraZeneca Research Collaboration
8. Palatin Technologies, Inc. Announces Pricing of $35 Million Private Placement of Common Stock and Warrants
9. Palatin Technologies, Inc. To Report Fiscal Year 2012 Fourth Quarter Results; Teleconference and Webcast to be held on September 11, 2012
10. Palatin Technologies Provides Update Regarding Its Obesity Research/Development Collaboration with AstraZeneca
11. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... The human skin is the largest organ, yet ... body part. Similar to the liver, or heart, the skin ... and grow. Recent reports from the mankatofreepress.com explained how caring ... important as other life supporting organs. The article suggests several ... reproduction, increase the appearance of skin, and fight off acne ...
(Date:6/18/2013)... Nasseo, Inc. today announces that it has ... hundreds of applicants by the Arizona Commerce Authority ... . The Arizona Innovation Challenge (AIC) awards the most ... granting a financial award to what it deems to ... of the art dental and orthopedic implant surface modification ...
(Date:6/18/2013)... June 18, 2013 The ... of the HELM biomolecular representation standard software toolkit ... licence. HELM (Hierarchical Editing Language for ... of biomolecules (e.g. proteins, nucleotides, antibody drug conjugates) ... sequence-based informatics methodologies impractical or unusable. HELM solves ...
(Date:6/18/2013)... , June 18, 2013 ... investment research firm, announces the initiation of ... French biopharmaceutical company developing and marketing products ... indications.      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... report examining the investment merits of BioAlliance ...
Breaking Biology Technology:Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin 2Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3
... Dec. 20, 2010 Metamark Genetics, Inc., ... and HistoRx, Inc., a diagnostics company developing ... care, today announced a multi-year licensing agreement. ... to the AQUA technology for the clinical ...
... Dec. 20, 2010 James M. Golubieski, president of ... Health Foundation affiliate, announced that Snowdon Inc., a company ... three-year contract by the Department of Defense (DoD) Program, ... new Defense Threat Reduction Agency (DTRA) contract, Snowdon may ...
... the Global Probiotics Council (GPC), a committee formed by Danone ... fourth annual Young Investigator Grant for Probiotics Research (YIGPRO). This ... to rising young stars. This year,s grant focus is on ... wellness. Applications will be accepted until February 15, 2011. ...
Cached Biology Technology:Metamark and HistoRx Announce Licensing Agreement for AQUA® Technology 2Foundation Venture Capital Group Company Receives $8.2 Million DoD Contract 2Foundation Venture Capital Group Company Receives $8.2 Million DoD Contract 3Fourth Annual Probiotics Grant Continues to Fuel Growth In Research 2Fourth Annual Probiotics Grant Continues to Fuel Growth In Research 3Fourth Annual Probiotics Grant Continues to Fuel Growth In Research 4
(Date:6/18/2013)... DNA and this modification can occur in millions ... scientists believed that this epigenetic phenomenon actively reduced ... of researchers from the University of Geneva (UNIGE), ... the Faculty of Medicine, reveals that this is ... may play both a passive and active role ...
(Date:6/18/2013)... research from the University of Adelaide shows that weight ... baby,s life is linked to a higher IQ at early school ... Health researchers, who analysed data from more than 13,800 children who ... Pediatrics , show that babies who put on 40% ... 1.5 points higher by the time they were six years of ...
(Date:6/17/2013)... in Vietnam and other locations with central nervous system ... a newly discovered virus, according to a study to ... journal of the American Society for Microbiology. Researchers have ... of 642 patients with central nervous system infections of ... of fecal samples from pigs and poultry, suggesting animals ...
Breaking Biology News(10 mins):The secret of DNA methylation 2IQ link to baby's weight gain in first month 2New virus discovered in patients with central nervous system infections 2New virus discovered in patients with central nervous system infections 3
... cluster of 45 genes coding for antibacterial drug ... cause of hospital-acquired infections worldwide. The study ... , "We expected to find resistance genes," said ... and Genomic Information Laboratory at France's National Center ...
... called Z-DNA, it can lead to the kind of genetic ... to a study by researchers at The University of Texas ... in advance of the Feb. 21 edition of the Proceedings ... time that the oddly shaped DNA can cause DNA breaks ...
... fit into a cell's nucleus. As DNA replicates, the strands ... blueprints of life ?but what happens if this process becomes ... division is the job of special enzymes called topoisomerases. How ... says U of T research. In a study published in ...
Cached Biology News:Supersized 'island' of resistance genes discovered in an infectious bacterium 2When good DNA goes bad 2When good DNA goes bad 3Researchers unravel DNA tangles and enzyme seamstresses 2
... is the ultimate tool for investigating dynamic ... applications previously have been limited at wavelengths ... do not transmit in the deep UV. ... spectroscopy, introduces a filter-based confocal system (the ...
... and Protein G bind specifically to Fc ... and Protein G conjugates are commonly used ... and immunoglobulin subtypes from serum, hybridoma ascites ... fluids. These reagents are also commonly used ...
... (10 min) assay can detect H2O2 or ... (ADHP). H2O2 oxidizes ADHP in a 1:1 ... (excitation at 530-571 nm, emission at 590-600 ... in a one-step, homogeneous, no wash assay ...
... Reverse-iT™ One-Step Kit is the ultimate ... RT-PCR. It has been specifically designed ... The Reverse-iT™ One-Step Kit combines the ... ABgene®s Thermoprime Plus DNA Polymerase to ...
Biology Products: